These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 23049743)
1. A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment. La Fleur L; Johansson AC; Roberg K PLoS One; 2012; 7(9):e44071. PubMed ID: 23049743 [TBL] [Abstract][Full Text] [Related]
2. Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells. Erjala K; Sundvall M; Junttila TT; Zhang N; Savisalo M; Mali P; Kulmala J; Pulkkinen J; Grenman R; Elenius K Clin Cancer Res; 2006 Jul; 12(13):4103-11. PubMed ID: 16818711 [TBL] [Abstract][Full Text] [Related]
3. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma. Geng S; Guo Y; Wang Q; Li L; Wang J Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085 [TBL] [Abstract][Full Text] [Related]
4. EGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells. Abhold EL; Kiang A; Rahimy E; Kuo SZ; Wang-Rodriguez J; Lopez JP; Blair KJ; Yu MA; Haas M; Brumund KT; Altuna X; Patel A; Weisman RA; Ongkeko WM PLoS One; 2012; 7(2):e32459. PubMed ID: 22384257 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC Cells. Wiechec E; Hansson KT; Alexandersson L; Jönsson JI; Roberg K Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468237 [TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cells. Benavente S; Huang S; Armstrong EA; Chi A; Hsu KT; Wheeler DL; Harari PM Clin Cancer Res; 2009 Mar; 15(5):1585-92. PubMed ID: 19190133 [TBL] [Abstract][Full Text] [Related]
7. Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab. Ather F; Hamidi H; Fejzo MS; Letrent S; Finn RS; Kabbinavar F; Head C; Wong SG PLoS One; 2013; 8(2):e56112. PubMed ID: 23405260 [TBL] [Abstract][Full Text] [Related]
8. The relationship between EMT, CD44 Johansson AC; La Fleur L; Melissaridou S; Roberg K J Oral Pathol Med; 2016 Oct; 45(9):640-646. PubMed ID: 26757432 [TBL] [Abstract][Full Text] [Related]
9. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition. Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987 [TBL] [Abstract][Full Text] [Related]
10. Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer. Keysar SB; Le PN; Anderson RT; Morton JJ; Bowles DW; Paylor JJ; Vogler BW; Thorburn J; Fernandez P; Glogowska MJ; Takimoto SM; Sehrt DB; Gan GN; Eagles-Soukup JR; Serracino H; Hirsch FR; Lucia MS; Thorburn A; Song JI; Wang XJ; Jimeno A Cancer Res; 2013 Jun; 73(11):3381-92. PubMed ID: 23576557 [TBL] [Abstract][Full Text] [Related]
11. Preclinical modeling of EGFR inhibitor resistance in head and neck cancer. Quesnelle KM; Wheeler SE; Ratay MK; Grandis JR Cancer Biol Ther; 2012 Aug; 13(10):935-45. PubMed ID: 22785204 [TBL] [Abstract][Full Text] [Related]
12. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt. Kuo SZ; Blair KJ; Rahimy E; Kiang A; Abhold E; Fan JB; Wang-Rodriguez J; Altuna X; Ongkeko WM BMC Cancer; 2012 Nov; 12():556. PubMed ID: 23176396 [TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas. Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606 [TBL] [Abstract][Full Text] [Related]
14. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2. Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934 [TBL] [Abstract][Full Text] [Related]
15. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition. Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877 [TBL] [Abstract][Full Text] [Related]
16. Identification of tumour initiating cells in feline head and neck squamous cell carcinoma and evidence for gefitinib induced epithelial to mesenchymal transition. Pang LY; Bergkvist GT; Cervantes-Arias A; Yool DA; Muirhead R; Argyle DJ Vet J; 2012 Jul; 193(1):46-52. PubMed ID: 22342216 [TBL] [Abstract][Full Text] [Related]
17. Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines. De Pauw I; Wouters A; Van den Bossche J; Deschoolmeester V; Baysal H; Pauwels P; Peeters M; Vermorken JB; Lardon F Cancer Biother Radiopharm; 2017 Sep; 32(7):229-238. PubMed ID: 28910149 [TBL] [Abstract][Full Text] [Related]
18. Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway. Maseki S; Ijichi K; Tanaka H; Fujii M; Hasegawa Y; Ogawa T; Murakami S; Kondo E; Nakanishi H Br J Cancer; 2012 Mar; 106(6):1196-204. PubMed ID: 22315058 [TBL] [Abstract][Full Text] [Related]
19. CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab. Niehr F; Weichert W; Stenzinger A; Budach V; Tinhofer I J Transl Med; 2015 Apr; 13():106. PubMed ID: 25890004 [TBL] [Abstract][Full Text] [Related]
20. Carbon ion irradiation withstands cancer stem cells' migration/invasion process in Head and Neck Squamous Cell Carcinoma (HNSCC). Moncharmont C; Guy JB; Wozny AS; Gilormini M; Battiston-Montagne P; Ardail D; Beuve M; Alphonse G; Simoëns X; Rancoule C; Rodriguez-Lafrasse C; Magné N Oncotarget; 2016 Jul; 7(30):47738-47749. PubMed ID: 27374096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]